The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1473798
Prognostic prediction and treatment options for gastric signet ring cell carcinoma: A SEER database analysis
Provisionally accepted- 1 The First Affiliated Hospital of Soochow University, Suzhou, China
- 2 Department of Gastrointestinal Surgery, Changzhou No.2 People's Hospital, Changzhou, China
In recent years, the overall incidence of gastric cancer has decreased. However, the incidence of gastric signet ring cell carcinoma (SRCC) is still increasing year by year. Compared with other subtypes (non-SRCC) such as adenocarcinoma, SRCC usually exhibits a more aggressive biological behaviour. Therefore, studying the prognostic differences and factors associated with SRCC is essential to improve the accuracy of diagnosis and prognosis. The purpose of this study was to investigate the prognostic factors influencing the prognosis of patients with SRCC and to develop personalised treatments for different subgroups of patients.The data on gastric SRCC patients and gastric adenocarcinoma (AC) patients from 1992 to 2020 was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. The data of gastric SRCC as the external validation group was reviewed from the First Affiliated Hospital of Soochow University. The overall survival (OS) and cancer specific survival (CSS) at 1 and 2 years were predicted for SRCC patients by constructing prognostic nomograms. A series of validation methods, including Akaike information criterion (AIC), decision curve analysis (DCA), calibration curve analysis, the concordance index (C-index) and the area under the receiver operating characteristic (AUC) curve, were used to verify the accuracy and reliability of the models. Results In all, 549 patients with SRCC were included after propensity score matching (PSM). Multivariate Cox regression analysis showed that T stage, N stage, M stage and surgical approach were independent risk factors affecting the prognosis of SRCC patients. A prognostic nomogram was constructed and validated as an accurate model for SRCC patients after scoring by receiver operating characteristic curve (ROC) curves and calibration plots. The patients were further divided into highrisk and low-risk groups, and the Kaplan-Meier curves showed that SRCC patients in the low-risk group could receive only surgery without chemotherapy, while chemotherapy plus surgery was a better option for SRCC patients in the high-risk group.The prognosis for SRCC was less favorable than that of AC in terms of CSS. The nomograms were developed and validated to predict OS and CSS in patients with SRCC, helping in developing appropriate individualized treatment schedules.
Keywords: gastric cancer, Signet ring cell carcinoma, SEER database, nomogram, Survival
Received: 31 Jul 2024; Accepted: 02 Oct 2024.
Copyright: © 2024 Yu, Yang, Li, Wang, Jin, Li, Zhang, Zhou and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jian Yang, The First Affiliated Hospital of Soochow University, Suzhou, China
Jie Wang, The First Affiliated Hospital of Soochow University, Suzhou, China
Kanghui Jin, The First Affiliated Hospital of Soochow University, Suzhou, China
Yifan Li, The First Affiliated Hospital of Soochow University, Suzhou, China
Zixiang Zhang, The First Affiliated Hospital of Soochow University, Suzhou, China
Jian Zhou, The First Affiliated Hospital of Soochow University, Suzhou, China
Yuchen Tang, The First Affiliated Hospital of Soochow University, Suzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.